List of redirects

Showing below up to 50 results in range #52,921 to #52,970.

52921. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
52922. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
52923. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
52924. The Living Guidelines: Recommendations for choosing diagnostic tests during follow up in patients with Chronic Stable Angina View the Current CLASS I Guidelines → Chronic stable angina patient follow-up
52925. The Living Guidelines: STEMI Anticoagulants as Ancillary Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction anticoagulant and antithrombotic therapy
52926. The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy View the Current CLASS III Guidelines → ST elevation myocardial infarction management of patients who were not reperfused
52927. The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy View the Current CLASS IIa Guidelines → ST elevation myocardial infarction management of patients who were not reperfused
52928. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin View the Current CLASS IIa Guidelines → ST elevation myocardial infarction aspirin therapy
52929. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin View the Current CLASS I Guidelines → ST elevation myocardial infarction aspirin therapy
52930. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel View the Current CLASS IIa Guidelines → ST elevation myocardial infarction secondary prevention
52931. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
52932. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
52933. The Living Guidelines: STEMI Facilitated PCI View the Current CLASS III Guidelines → ST elevation myocardial infarction facilitated percutaneous coronary intervention
52934. The Living Guidelines: STEMI Facilitated PCI View the Current CLASS IIb Guidelines → ST elevation myocardial infarction facilitated percutaneous coronary intervention
52935. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS III Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
52936. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS IIa Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
52937. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS IIb Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
52938. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS I Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
52939. The Living Guidelines: STEMI Influenza Vaccination View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
52940. The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion View the Current CLASS III Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
52941. The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion View the Current CLASS IIb Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
52942. The Living Guidelines: STEMI Recommendations ACE Inhibitors Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
52943. The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy View the Current CLASS IIa Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
52944. The Living Guidelines: STEMI Recommendations for Additional Management Considerations for Beta Blocker Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction beta blocker therapy
52945. The Living Guidelines: STEMI Recommendations for Aldosterone Blockers Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
52946. The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy View the Current CLASS IIb Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
52947. The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
52948. The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy View the Current CLASS III Guidelines → ST elevation myocardial infarction beta blocker therapy
52949. The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy View the Current CLASS IIa Guidelines → ST elevation myocardial infarction beta blocker therapy
52950. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIa Guidelines → ST elevation myocardial infarction secondary prevention
52951. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIb Guidelines → ST elevation myocardial infarction secondary prevention
52952. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
52953. The Living Guidelines: STEMI Reperfusion View the Current CLASS I Guidelines → ST elevation myocardial infarction reperfusion therapy
52954. The Living Guidelines: STEMI Thienopyridines View the Current CLASS IIa Guidelines → ST elevation myocardial infarction thienopyridine therapy
52955. The Living Guidelines: STEMI Thienopyridines View the Current CLASS I Guidelines → ST elevation myocardial infarction thienopyridine therapy
52956. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure clinical assessment
52957. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIb Guidelines → Congestive heart failure clinical assessment
52958. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure clinical assessment
52959. The Living Guidelines: Treatment of Special Populations. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of special populations
52960. The Living Guidelines: Treatment of Special Populations. View the Current CLASS I Guidelines → Congestive heart failure treatment of special populations
52961. The Living Guidelines: UA/NSTEMI Anticoagulant Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52962. The Living Guidelines: UA/NSTEMI Anticoagulant Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52963. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
52964. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
52965. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
52966. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
52967. The Living Guidelines: UA/NSTEMI Recomendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52968. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52969. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52970. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)